Newsroom

In a groundbreaking new study, researchers have 3D printed unique fluid channels at the micron scale that could automate production of diagnostics, sensors, and assays used for a variety of medical tests and other applications.

NIH, working in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), today announced a third round of contract awards for scale-up and manufacturing of new COVID-19 testing technologies.

An ideal infectious disease test is accurate, fast, cheap, and can be performed at home. Read more at Biocompare Future Lab.

Artificial intelligence can speed the development of 3D-printed bioscaffolds that help injuries heal, according to researchers.

Neuroscientists distinguish brain regions based on what they do, but now have a new way to overlay information about how they are built, too.

Researchers have created a new PET imaging agent that detects signs of inflammation. Such a tracer could aid diagnosis and study of diseases ranging from cardiovascular disease to cancer to COVID-19.

The NCI and the NIBIB chose the seven projects from nearly 200 different ideas. The projects represent a broad range of solutions for immediate public health needs related to the pandemic, and several focus on solutions for medically underserved communities and people with limited access to healthcare. Read more Health IT Analytics.

NIH has awarded seven contracts to companies and academic institutions to develop digital health solutions that help address the COVID-19 pandemic.

NIH announced $129.3 million in scale-up and manufacturing support for a new set of COVID-19 testing technologies as part of RADx. These tests add to initial awards made to seven companies on July 31, 2020.